Key result
Sera from cardiac transplant patients with TxCAD showed reactivity in 71.4% of cases and isolated 18 positive cDNA clones, indicating a high diversity of non-HLA antigens involved in TxCAD.
Case-Control (n=12)
A high diversity of non-HLA antigens, likely autoantigens, are targeted by antibodies in patients with transplant-associated coronary artery disease.
Diverse non-HLA antigens may contribute to TxCAD; animal data leave open human validation and clinical relevance.
BACKGROUND: Antibodies to endothelial derived non-human leukocyte antigens (HLA) have been associated with transplant (Tx)-associated coronary artery disease (CAD) after cardiac transplantation; however, few have been identified. The aim of this study was to screen a human coronary artery endothelial cell cDNA library with patient sera to establish the diversity and nature of the target antigens. METHODS: A human coronary artery endothelial cell cDNA library was screened with sera from seven long-term cardiac transplant patients with angiographically diagnosed TxCAD and sera from five healthy volunteers. RESULTS: Of the seven patients' sera, five showed reactivity, as did sera from two of the five normal subjects. Eighteen positive cDNA clones were isolated by TxCAD sera; DNA sequence analysis and DNA database searching identified all but one clone; 16 were nuclear or cytoplasmic proteins and 1 of them was the cell surface protein neuropilin 2. Five clones were targeted by normal sera. A different spectrum of reactive clones was identified by the sera of each patient where reactive clones were evident. CONCLUSIONS: A high diversity of non-HLA antigens, probably autoantigens, are involved in the pathogenesis of TxCAD.
No takes yet. Share an insight, caveat, or question.
Bates et al. (2003) conducted a case-control in Transplant-associated coronary artery disease (n=12). TxCAD patient sera vs. Healthy volunteer sera was evaluated on Reactivity to human coronary artery endothelial cell cDNA library. Sera from cardiac transplant patients with TxCAD showed reactivity in 71.4% of cases and isolated 18 positive cDNA clones, indicating a high diversity of non-HLA antigens involved in TxCAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: